Jefferies analyst Brandon Couillard raised his price target but lowered estimates on Buy-rated Exact Sciences (NASDAQ: EXAS) following Q2 results.Couillard ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE